TY - JOUR
T1 - Delineation of IL-5 domains predicted to engage the IL-5 receptor complex
AU - Dickason, Richard R.
AU - Huston, Marilyn M.
AU - Huston, David P.
PY - 1996/2/1
Y1 - 1996/2/1
N2 - IL-5 is an interdigitating homodimeric glycoprotein and a member of the helical bundle family of cytokines. IL-5 is a potent activator of eosinophils and a specific promoter of their differentiation. This activity has implicated IL-5 in the pathogenesis of asthma and allergic disease. A detailed understanding of IL-5 structure and function is required to develop immunomodulators of IL-5-mediated inflammatory responses. We generated a panel of neutralizing anti-IL-5 mAbs which were used to map functional domains on IL-5. In addition, the nucleotide sequences for human IL-5, murine IL-5, rat IL-5, and eight human/murine IL-5 chimeras were engineered and expressed in COS-7 cells. These recombinant cytokines and mAbs were used in TF-1 bioassays to identify five functional epitopes on the tertiary structure of IL-5. Residues responsible for the species-specific activity of human IL- 5 were identified with the murine BCL1 bioassay. One set of epitopes cluster around the helix A-loop 2 region, which is predicted to engage the IL-5 receptor β-chain. The second set of epitopes as well as the species specificity domain cluster around the loop 3-helix D region, which is predicted to engage the IL-5 receptor α-chain. Together, these analyses target the A/D helical face of IL-5 as the region involved in receptor engagement.
AB - IL-5 is an interdigitating homodimeric glycoprotein and a member of the helical bundle family of cytokines. IL-5 is a potent activator of eosinophils and a specific promoter of their differentiation. This activity has implicated IL-5 in the pathogenesis of asthma and allergic disease. A detailed understanding of IL-5 structure and function is required to develop immunomodulators of IL-5-mediated inflammatory responses. We generated a panel of neutralizing anti-IL-5 mAbs which were used to map functional domains on IL-5. In addition, the nucleotide sequences for human IL-5, murine IL-5, rat IL-5, and eight human/murine IL-5 chimeras were engineered and expressed in COS-7 cells. These recombinant cytokines and mAbs were used in TF-1 bioassays to identify five functional epitopes on the tertiary structure of IL-5. Residues responsible for the species-specific activity of human IL- 5 were identified with the murine BCL1 bioassay. One set of epitopes cluster around the helix A-loop 2 region, which is predicted to engage the IL-5 receptor β-chain. The second set of epitopes as well as the species specificity domain cluster around the loop 3-helix D region, which is predicted to engage the IL-5 receptor α-chain. Together, these analyses target the A/D helical face of IL-5 as the region involved in receptor engagement.
UR - http://www.scopus.com/inward/record.url?scp=0030051655&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030051655&partnerID=8YFLogxK
M3 - Article
C2 - 8557976
AN - SCOPUS:0030051655
SN - 0022-1767
VL - 156
SP - 1030
EP - 1037
JO - Journal of Immunology
JF - Journal of Immunology
IS - 3
ER -